Security Snapshot

Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) Institutional Ownership

CUSIP: G9008W105

13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

43

Shares (Excl. Options)

15,977,751

Price

$10.49

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Class A ordinary shares, par value $0.0001 per share
Symbol
TDAC on Nasdaq
Shares outstanding
17,244,009
Price per share
$10.56
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
15,977,751
Total reported value
$167,444,705
% of total 13F portfolios
0%
Share change
+770,803
Value change
+$8,075,273
Number of holders
43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • TDAC - Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share is tracked under CUSIP G9008W105.
  • 43 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 43 to 14 between Q4 2025 and Q1 2026.
  • Reported value moved from $167,444,705 to $59,712,759.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 43 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP G9008W105?
CUSIP G9008W105 identifies TDAC - Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WOLVERINE ASSET MANAGEMENT LLC 9% +15% $16,069,623 +$2,089,212 1,557,134 +15% WOLVERINE ASSET MANAGEMENT LLC 30 Sep 2025
AQR CAPITAL MANAGEMENT LLC 6.4% -25% $11,087,889 -$3,880,911 1,099,989 -26% AQR Capital Management, LLC 31 Mar 2025
BANK OF MONTREAL /CAN/ 4.6% -19% $8,240,000 -$2,060,000 800,000 -20% Bank of Montreal 30 Jun 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2.3% -58% $4,032,000 -$5,040,000 400,000 -56% Healthcare of Ontario Pension Plan Trust Fund 31 Mar 2025

As of 31 Dec 2025, 43 institutional investors reported holding 15,977,751 shares of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC). This represents 93% of the company’s total 17,244,009 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WOLVERINE ASSET MANAGEMENT LLC 7.9% 1,367,115 -12% 0.2% $14,341,036
Magnetar Financial LLC 7.5% 1,300,000 0% 0.13% $13,637,000
AQR Arbitrage LLC 6.4% 1,096,989 0% 0.24% $11,507,415
LMR Partners LLP 4.6% 800,000 0% 0.08% $8,392,000
Hudson Bay Capital Management LP 3.8% 650,000 0% 0.04% $6,818,500
First Trust Capital Management L.P. 3.8% 649,998 0% 0.41% $6,818,479
TENOR CAPITAL MANAGEMENT Co., L.P. 3.7% 635,399 0% 0.09% $6,665,336
Karpus Management, Inc. 3.6% 613,425 -0.54% 0.2% $6,416,426
Alberta Investment Management Corp 3.5% 600,000 0.04% $6,294,000
Linden Advisors LP 3.5% 600,000 0% 0.04% $6,294,000
Polar Asset Management Partners Inc. 3.5% 600,000 0% 0.12% $6,294,000
Radcliffe Capital Management, L.P. 2.9% 505,514 +0.24% 0.29% $5,295,259
RIVERNORTH CAPITAL MANAGEMENT, LLC 2.9% 500,000 +25% 0.25% $5,230,000
PICTON MAHONEY ASSET MANAGEMENT 2.8% 475,002 0% 0.05% $4,975,646
Periscope Capital Inc. 2.3% 400,090 0% 0.81% $4,190,943
Glazer Capital, LLC 2.3% 399,797 -3.3% 0.11% $4,182,000
GOLDMAN SACHS GROUP INC 2.2% 385,010 0% 0% $4,027,205
MIZUHO SECURITIES USA LLC 2.1% 366,110 +0.86% 0.06% $3,789,239
MMCAP International Inc. SPC 2% 350,000 0% 0.37% $3,671,500
D. E. Shaw & Co., Inc. 2% 346,900 0% 0% $3,638,981
WHITEBOX ADVISORS LLC 1.8% 305,000 0% 0.05% $3,199,450
METEORA CAPITAL, LLC 1.6% 270,843 0.24% $2,833,018
Westchester Capital Management, LLC 1.4% 248,852 0% 0.12% $2,610,458
Shaolin Capital Management LLC 1.3% 218,094 +8.5% 0.09% $2,287,806
Wealthspring Capital LLC 1.2% 207,230 0% 0.51% $2,167,626

Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 5,655,712 $59,712,759 -$1,888,949 $10.56 14
2025 Q4 15,977,751 $167,444,705 +$8,075,273 $10.49 43
2025 Q3 15,031,948 $155,536,911 +$15,253,748 $10.35 40
2025 Q2 13,959,688 $142,484,311 +$30,107,600 $10.27 38
2025 Q1 11,160,102 $112,476,282 +$112,476,282 $10.08 30
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .